cerrar
Tagged with M

Preclinical and Clinical Trial Requirements: Norway
A brief overview of the situation regarding preclinical and clinical trial requirements in Norwegian Pharma. Prepared in association with DLA Piper, a…

Regulatory, Pricing and Reimbursement Overview: Norway
An insight into regulatory, pricing and reimbursement overview in Norwegian Pharma. Prepared in association with DLA Piper, a leading law firm in…

Biosimilars & Biologics: Singapore
A brief overview of the situation regarding biosimilars & biologics in Singaporean Pharma. Prepared in association with Drew & Napier LLC,…

Orphan Drugs & Rare Diseases: Singapore
The ins and outs of orphan drugs & rare diseases in Singaporean Pharma. Prepared in association with Drew & Napier LLC, this is an extract…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Singapore
Cannabinoid drugs, medicinal cannabis and opioid drugs in Singaporean Pharma - a legal guide. Prepared in association with Drew & Napier LLC,…

Joan Shen – CEO, I-Mab Biopharma
Dr Joan Shen, CEO of I-Mab Biopharma, shares her impressive career journey across companies like Pfizer, Janssen and Jiangsu Hengrui, before joining…

Desmond Hau – CEO, Pangenia Group
Dr Desmond Hau, CEO of Pangenia Inc, sits down with PharmaBoardroom to shed light on the company’s progress since taking the reins three years ago.…

Pharma Faces: Jorge Alderete, ALK Americas
Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish mid-cap, the challenges in…

The Moroccan Firms Bringing MNCs to Africa
Some of the more entrepreneurial Moroccan local laboratories have spotted an opening to leverage their knowledge of Sub Saharan African markets and to…

What Can a Plasma ‘Alliance’ do for COVID-19?
A newly formed ‘Plasma Alliance’ of the world’s leading blood plasma companies believed that plasma from those who have recovered from COVID-19…

Moroccan Pharma Companies to Know
Morocco, one of the most significant pharmaceutical markets in Africa, boasts a number of domestic firms. Here we highlight eight of the most…

Jorge Alderete – President, ALK Americas & SVP…
Jorge Alderete, president of ALK Americas, outlines the Danish mid-cap’s strategy in the challenging US market, including innovative market access…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here